Cyberbeveiliging voor medische hulpmiddelen (MDR/IVDR)
Verbonden medische hulpmiddelen en software als medisch hulpmiddel moeten volgens MDR en IVDR veilig worden ontwikkeld, gedocumenteerd en in het veld bewaakt. Complass begeleidt fabrikanten en leveranciers in de medische technologie van het dreigingsmodel tot de melding van kwetsbaarheden.
Compliancemanagement in 20 secondenProject, volgende stap, checklist, verklaring van toepasselijkheid, auditpakket. Beispieldaten der Demo-Firma.
Wat is Medische hulpmiddelen?
De Verordening medische hulpmiddelen (EU) 2017/745 (MDR) en de Verordening in-vitrodiagnostica (EU) 2017/746 (IVDR) vereisen dat software volgens de stand van de techniek wordt ontwikkeld, dat het risicobeheer informatiebeveiliging omvat en dat fabrikanten minimumeisen voor hardware, IT-netwerken en IT-beveiligingsmaatregelen vastleggen. Richtsnoer MDCG 2019-16 Rev. 1 licht toe wat dat in de praktijk betekent.
Actualiteit van de inhoud:
Is het op mij van toepassing?
De eisen gelden voor fabrikanten van medische hulpmiddelen en in-vitrodiagnostica die software bevatten of zelf software zijn. Leveranciers van elektronica, embedded software, radiomodules of contractproductie worden indirect geraakt: fabrikanten geven de eisen via het kwaliteitsmanagementsysteem en contracten aan hen door en verwachten bijvoorbeeld een SBOM, een beveiligingsdatablad en toezeggingen over updates.
Medische hulpmiddelen zijn uitgezonderd van de Cyber Resilience Act. Componenten met digitale elementen die ook zelfstandig of buiten de medische technologie worden verkocht, vallen daarentegen in de regel wel onder de CRA. Fabrikanten van medische hulpmiddelen en in-vitrodiagnostica kunnen vanaf een middelgrote omvang bovendien onder NIS2 vallen (bijlage 2 BSIG).
Dit overzicht vervangt geen juridisch advies. De wettelijke of normatieve tekst is doorslaggevend; in Complass toetst u de toepasselijkheid aan de hand van een handleiding op basis van de vindplaatsen.
Rechtsgrondslag
Art. 2 MDRArticle 2 MDRDefinitionsFor the purposes of this Regulation, the following definitions apply: (1) ‘medical device’ means any instrument, apparatus, appliance, software, implant, reagent, material or other article intended by the manufacturer to be used, alone or in combination, for human beings for one or more of the following specific medical purposes: - diagnosis, prevention, monitoring, prediction, prognosis, treatment or alleviation of …Stand: 05.10.2026 · Bron: EUR-Lex – consolidated version of 19.07.2026Origineel openen (EUR-Lex – consolidated version of 19.07.2026) ↗Definities, o.a. medisch hulpmiddel en accessoire
Art. 10 MDRArticle 10 MDRGeneral obligations of manufacturers1. When placing their devices on the market or putting them into service, manufacturers shall ensure that they have been designed and manufactured in accordance with the requirements of this Regulation. 2. Manufacturers shall establish, document, implement and maintain a system for risk management as described in Section 3 of Annex I. 3. Manufacturers shall conduct a clinical evaluation in accordance with the …Stand: 05.10.2026 · Bron: EUR-Lex – consolidated version of 19.07.2026Origineel openen (EUR-Lex – consolidated version of 19.07.2026) ↗Algemene verplichtingen van fabrikanten
Anhang I Abschn. 17.2 MDRAnnex I Section 17.2 MDRFor devices that incorporate software or for software that are devices in themselves, the software shall be developed and manufactured in accordance with the state of the art taking into account the principles of development life cycle, risk management, including information security, verification and validation.Stand: 05.10.2026 · Bron: EUR-Lex – consolidated version of 19.07.2026Origineel openen (EUR-Lex – consolidated version of 19.07.2026) ↗Softwarelevenscyclus, risicobeheer inclusief informatiebeveiliging
Anhang I Abschn. 17.4 MDRAnnex I Section 17.4 MDRManufacturers shall set out minimum requirements concerning hardware, IT networks characteristics and IT security measures, including protection against unauthorised access, necessary to run the software as intended.Stand: 05.10.2026 · Bron: EUR-Lex – consolidated version of 19.07.2026Origineel openen (EUR-Lex – consolidated version of 19.07.2026) ↗Minimumeisen voor hardware, IT-netwerken en IT-beveiligingsmaatregelen
Art. 83 MDRArticle 83 MDRPost-market surveillance system of the manufacturer1. For each device, manufacturers shall plan, establish, document, implement, maintain and update a post-market surveillance system in a manner that is proportionate to the risk class and appropriate for the type of device. That system shall be an integral part of the manufacturer's quality management system referred to in Article 10(9). 2. The post-market surveillance system shall be suited to actively and …Stand: 05.10.2026 · Bron: EUR-Lex – consolidated version of 19.07.2026Origineel openen (EUR-Lex – consolidated version of 19.07.2026) ↗Systeem voor monitoring na het in de handel brengen
Art. 87 MDRArticle 87 MDRReporting of serious incidents and field safety corrective actions1. Manufacturers of devices made available on the Union market, other than investigational devices, shall report, to the relevant competent authorities, in accordance with Articles 92(5) and (7), the following: - (a) any serious incident involving devices made available on the Union market, except expected side-effects which are clearly documented in the product information and quantified in the technical …Stand: 05.10.2026 · Bron: EUR-Lex – consolidated version of 19.07.2026Origineel openen (EUR-Lex – consolidated version of 19.07.2026) ↗Melding van ernstige incidenten en veiligheidscorrigerende maatregelen in het veld
Anhang I Abschn. 16.2 IVDRAnnex I Section 16.2 IVDRFor devices that incorporate software or for software that are devices in themselves, the software shall be developed and manufactured in accordance with the state of the art taking into account the principles of development life cycle, risk management, including information security, verification and validation.Stand: 05.10.2026 · Bron: EUR-Lex – consolidated version of 10.01.2025Origineel openen (EUR-Lex – consolidated version of 10.01.2025) ↗Overeenkomstige eis voor software van in-vitrodiagnostica
Art. 2 Abs. 2 CRAArtikel 2 Verordening cyberweerbaarheidToepassingsgebied1. Deze verordening is van toepassing op op de markt aangeboden producten met digitale elementen waarvan het beoogde doel of het redelijkerwijs voorzienbaar gebruik een directe of indirecte logische of fysieke gegevensverbinding met een apparaat of netwerk omvat. 2. Deze verordening is niet van toepassing op producten met digitale elementen waarop de volgende rechtshandelingen van de Unie van toepassing zijn: - a) …Stand: 06.10.2026 · Bron: EUR-Lex – OJ L 2024/2847, 20.11.2024, corrigenda incorporated: OJ L 2025/90555, 2.7.2025; OJ L 2025/90828, 17.10.2025Origineel openen (EUR-Lex – OJ L 2024/2847, 20.11.2024, corrigenda incorporated: OJ L 2025/90555, 2.7.2025; OJ L 2025/90828, 17.10.2025) ↗Uitzondering van medische hulpmiddelen van de Cyber Resilience Act
Belangrijke data
Date of application of the MDR · Art. 123(2) MDRArticle 123 MDREntry into force and date of application1. This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union. 2. It shall apply from 26 May 2021 . 3. By way of derogation from paragraph 2: - (a) Articles 35 to 50 shall apply from 26 November 2017. However, from that date until 26 May 2021 , the obligations on notified bodies pursuant to Articles 35 to 50 shall apply only to those …Stand: 05.10.2026 · Bron: EUR-Lex – consolidated version of 19.07.2026Origineel openen (EUR-Lex – consolidated version of 19.07.2026) ↗
Date of application of the IVDR · Art. 113(2) IVDRArticle 113 IVDREntry into force and date of application1. This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union. 2. It shall apply from 26 May 2022. 3. By way of derogation from paragraph 2: ————— - (b) Articles 31 to 46 and Article 96 shall apply from 26 November 2017. However, from that date until 26 May 2022 the obligations on notified bodies pursuant to Articles 31 to 46 shall …Stand: 05.10.2026 · Bron: EUR-Lex – consolidated version of 10.01.2025Origineel openen (EUR-Lex – consolidated version of 10.01.2025) ↗
MDR legacy devices: QMS in accordance with Art. 10(9) put in place and formal application lodged with a notified body (condition of the transitional period) · Art. 120(3c)(d) and (e) MDRArticle 120 MDRTransitional provisions1. From 26 May 2021 , any publication of a notification in respect of a notified body in accordance with Directives 90/385/EEC and 93/42/EEC shall become void. 2. Certificates issued by notified bodies in accordance with Directives 90/385/EEC and 93/42/EEC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex 4 to …Stand: 05.10.2026 · Bron: EUR-Lex – consolidated version of 19.07.2026Origineel openen (EUR-Lex – consolidated version of 19.07.2026) ↗
MDR legacy devices: written agreement signed with the notified body (condition of the transitional period) · Art. 120(3c)(e) MDRArticle 120 MDRTransitional provisions1. From 26 May 2021 , any publication of a notification in respect of a notified body in accordance with Directives 90/385/EEC and 93/42/EEC shall become void. 2. Certificates issued by notified bodies in accordance with Directives 90/385/EEC and 93/42/EEC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex 4 to …Stand: 05.10.2026 · Bron: EUR-Lex – consolidated version of 19.07.2026Origineel openen (EUR-Lex – consolidated version of 19.07.2026) ↗
Obligations relating to the first Eudamed modules (actors, UDI/devices, notified bodies and certificates, market surveillance) apply · Art. 123(3)(d) MDR in conjunction with Decision (EU) 2025/2371Article 123 MDREntry into force and date of application1. This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union. 2. It shall apply from 26 May 2021 . 3. By way of derogation from paragraph 2: - (a) Articles 35 to 50 shall apply from 26 November 2017. However, from that date until 26 May 2021 , the obligations on notified bodies pursuant to Articles 35 to 50 shall apply only to those …Stand: 05.10.2026 · Bron: EUR-Lex – consolidated version of 19.07.2026Origineel openen (EUR-Lex – consolidated version of 19.07.2026) ↗
IVDR legacy devices of class B and sterile class A: formal application lodged with a notified body no later than · Art. 110(3c)(e)(iii) IVDRArticle 110 IVDRTransitional provisions1. From 26 May 2022, any publication of a notification in respect of a notified body in accordance with Directive 98/79/EC shall become void. 2. Certificates issued by notified bodies in accordance with Directive 98/79/EC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex VI to Directive 98/79/EC which shall become …Stand: 05.10.2026 · Bron: EUR-Lex – consolidated version of 10.01.2025Origineel openen (EUR-Lex – consolidated version of 10.01.2025) ↗
IVDR legacy devices of class B and sterile class A: written agreement with the notified body no later than · Art. 110(3c)(f)(iii) IVDRArticle 110 IVDRTransitional provisions1. From 26 May 2022, any publication of a notification in respect of a notified body in accordance with Directive 98/79/EC shall become void. 2. Certificates issued by notified bodies in accordance with Directive 98/79/EC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex VI to Directive 98/79/EC which shall become …Stand: 05.10.2026 · Bron: EUR-Lex – consolidated version of 10.01.2025Origineel openen (EUR-Lex – consolidated version of 10.01.2025) ↗
End of the MDR transitional period for class III and class IIb implantable devices (with exceptions), under the conditions of Art. 120(3c) · Art. 120(3a)(a) MDRArticle 120 MDRTransitional provisions1. From 26 May 2021 , any publication of a notification in respect of a notified body in accordance with Directives 90/385/EEC and 93/42/EEC shall become void. 2. Certificates issued by notified bodies in accordance with Directives 90/385/EEC and 93/42/EEC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex 4 to …Stand: 05.10.2026 · Bron: EUR-Lex – consolidated version of 19.07.2026Origineel openen (EUR-Lex – consolidated version of 19.07.2026) ↗
End of the IVDR transitional period for devices with a certificate under Directive 98/79/EC and for class D, under the conditions of Art. 110(3c) · Art. 110(3a), (3b)(a) IVDRArticle 110 IVDRTransitional provisions1. From 26 May 2022, any publication of a notification in respect of a notified body in accordance with Directive 98/79/EC shall become void. 2. Certificates issued by notified bodies in accordance with Directive 98/79/EC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex VI to Directive 98/79/EC which shall become …Stand: 05.10.2026 · Bron: EUR-Lex – consolidated version of 10.01.2025Origineel openen (EUR-Lex – consolidated version of 10.01.2025) ↗
End of the MDR transitional period for other class IIb, class IIa, class I sterile or with a measuring function, and for devices that require a notified body only under the MDR · Art. 120(3a)(b), (3b) MDRArticle 120 MDRTransitional provisions1. From 26 May 2021 , any publication of a notification in respect of a notified body in accordance with Directives 90/385/EEC and 93/42/EEC shall become void. 2. Certificates issued by notified bodies in accordance with Directives 90/385/EEC and 93/42/EEC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex 4 to …Stand: 05.10.2026 · Bron: EUR-Lex – consolidated version of 19.07.2026Origineel openen (EUR-Lex – consolidated version of 19.07.2026) ↗
End of the IVDR transitional period for class C · Art. 110(3b)(b) IVDRArticle 110 IVDRTransitional provisions1. From 26 May 2022, any publication of a notification in respect of a notified body in accordance with Directive 98/79/EC shall become void. 2. Certificates issued by notified bodies in accordance with Directive 98/79/EC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex VI to Directive 98/79/EC which shall become …Stand: 05.10.2026 · Bron: EUR-Lex – consolidated version of 10.01.2025Origineel openen (EUR-Lex – consolidated version of 10.01.2025) ↗
End of the IVDR transitional period for class B and sterile class A · Art. 110(3b)(c) IVDRArticle 110 IVDRTransitional provisions1. From 26 May 2022, any publication of a notification in respect of a notified body in accordance with Directive 98/79/EC shall become void. 2. Certificates issued by notified bodies in accordance with Directive 98/79/EC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex VI to Directive 98/79/EC which shall become …Stand: 05.10.2026 · Bron: EUR-Lex – consolidated version of 10.01.2025Origineel openen (EUR-Lex – consolidated version of 10.01.2025) ↗
Datum van toepassing en overgangstermijnen volgens de geconsolideerde versies van MDR en IVDR. Een voorstel van de Commissie van 16.12.2025 (COM(2025) 1023) voorziet in aanvullende meldplichten voor kwetsbaarheden; het is nog niet vastgesteld.
Hoe Complass helpt
Zeven fasen over de levenscyclus
Indeling en rol, veilige ontwikkeling met risicobeheer, minimumeisen voor de IT-omgeving, technische documentatie, monitoring na het in de handel brengen en vigilantie, plus een eigen fase voor leveranciers.
Eisencatalogi
Cybereisen uit MDR en IVDR, maatregelen volgens MDCG 2019-16 en beveiligingsactiviteiten in de levenscyclus met status en bewijs, te koppelen aan CRA, IEC 62443 en ISO 27001.
Sjablonen
o.a. beveiligingsplan, dreigingsmodel, beveiligingsrisicodossier, SBOM-register, minimumeisen voor de IT-omgeving, beleid voor gecoördineerde bekendmaking, patch- en updateconcept en beveiligingsovereenkomst met leveranciers.
Kwetsbaarheden en incidenten
SBOM-vergelijking met bekende kwetsbaarheden, registratie van incidenten en overzicht van meldtermijnen.
De fasen in de module
Qualification, role and demarcation
Secure development across the lifecycle
Minimum requirements for the IT environment and operator information
Technical documentation and conformity assessment
After placing on the market: surveillance, vulnerabilities, updates and vigilance
Suppliers to the medical technology industry
Implementation in Complass
Catalogus: MDR/IVDR requirements relevant to cybersecurity
Het branchesjabloon «Medische technologie» selecteert vooraf het normenkader voor MDR en IVDR en de modules die u nodig hebt voor het dreigingsmodel, kwetsbaarheden en leveranciers.
beschikbaar
Branchesjabloon: Medische technologie
Cyberbeveiliging voor medische hulpmiddelen onder MDR en IVDR
Kwetsbaarheden en SBOM
Risicomanagement
MITRE ATT&CK voor het dreigingsmodel
Supplier Management
vanaf 476 € per maand excl. btw in het pakket Start, grootte S, bij jaarlijkse betaling
Alle prijzen gelden voor bedrijven, niet voor consumenten. Ze zijn netto excl. btw bij jaarlijkse betaling; bij maandelijkse betaling geldt een toeslag van 15 %. Stand 16/10/2026. Enterprise en concerns op aanvraag.
Veelgestelde vragen
Wij leveren alleen elektronica en firmware aan fabrikanten van medische technologie. Heeft dit gevolgen voor ons?+
Indirect wel: uw klanten moeten de cybereisen van de MDR aantonen en verwachten daarvoor gegevens en toezeggingen van u. Verkoopt u de component ook aan andere sectoren, dan geldt daarvoor in de regel aanvullend de Cyber Resilience Act. De module bevat een eigen fase voor leveranciers.
Vervangt de module ons kwaliteitsmanagementsysteem?+
Nee. Complass structureert de cybereisen en het bewijs en laat zich integreren in uw bestaande QMS; conformiteitsbeoordeling en goedkeuringen blijven bij u en uw aangemelde instantie.
Zijn normen zoals IEC 81001-5-1 inbegrepen?+
De module beschrijft de activiteiten in eigen woorden met verwijzing naar de paragrafen. De normtekst zelf betrekt u via de normenhandel; uittreksels uit uw gelicentieerde uitgave kunt u in het project opslaan.
Test Complass met uw eigen gegevens
Maak uw proefaccount zelf aan, desgewenst met een voorbeeldproject per kader. Wilt u Complass liever eerst zien, vraag dan een demo aan.